Ranking // by sector, by revenue growth

Healthcare stocks by revenue growth

The 13 companies we cover Healthcare by SEC SIC code, largest revenue growth first. Each figure is from the company's own annual report, fiscal years ending 2025-12-28 to 2025-12-31. An order by a figure is the figure, sorted: nothing here says a company is a better or worse holding.

Every figure on this page is free to read, dated and sourced; no column is held back for a paid plan.

Median revenue growth: +11.8% over 13 companies, 13 distinct values.

RankCompany
⊙
EVIDENCE — filed/published fact
SourceSEC SIC code from the company's EDGAR submissions record, grouped into sectors by lib/sic-sector
As ofissuer records read up to 90 days before 2026-11-09
Open the source document →
Revenue growth
⊙
INFERENCE — derived by arithmetic
SourceRevenue growth from SEC XBRL company facts, via the fundamentals screener
As offiscal years ending 2025-12-28 to 2025-12-31
HowLatest fiscal year revenue against the year before, from the annual reports. A company whose fiscal year end is undated, or older than the annual-filing window (470 days), is named below and not ranked.
Fiscal year end
1LLY Eli Lilly+44.7%2025-12-31
2ADUS+23.2%2025-12-31
3USPH+16.3%2025-12-31
4NHC+16.1%2025-12-31
5ATRC+14.9%2025-12-31
6LMAT+13.5%2025-12-31
7UNH UnitedHealth+11.8%2025-12-31
8ABBV AbbVie+8.6%2025-12-31
9JNJ Johnson & Johnson+6.0%2025-12-28
10ABT Abbott+5.7%2025-12-31
11MRK Merck+1.3%2025-12-31
12PFE Pfizer-1.6%2025-12-31
13UTMD-5.8%2025-12-31

Who is in the group: sector is our grouping of the four-digit SIC code on each company's own EDGAR record, the grouping the S&P 500 map uses; it is not GICS, which is licensed.

The same companies by market cap, P/E ratio, net margin.

Revenue growth in other groups: mega-cap, large-cap, mid-cap, small-cap, technology, financial, consumer, industrial, energy, NYSE-listed, Nasdaq-listed, Delaware-incorporated, non-Delaware US.

Every ranking: the ranking grid. Every list: stock lists.